AKTide-2TAkt/PKB substrate (synthetic) CAS# 324029-01-8 |
2D Structure
- MK-2206 dihydrochloride
Catalog No.:BCC1274
CAS No.:1032350-13-2
- Perifosine
Catalog No.:BCC3673
CAS No.:157716-52-4
- Everolimus (RAD001)
Catalog No.:BCC3594
CAS No.:159351-69-6
- Temsirolimus
Catalog No.:BCC3678
CAS No.:162635-04-3
- Rapamycin (Sirolimus)
Catalog No.:BCC3592
CAS No.:53123-88-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 324029-01-8 | SDF | Download SDF |
PubChem ID | 90488759 | Appearance | Powder |
Formula | C74H114N28O20 | M.Wt | 1715.89 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 1 mg/ml in water | ||
Sequence | ARKRERTYSFGHHA | ||
SMILES | CC(C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CO)C(=O)NC(CC2=CC=CC=C2)C(=O)NCC(=O)NC(CC3=CNC=N3)C(=O)NC(CC4=CNC=N4)C(=O)NC(C)C(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)N)O | ||
Standard InChIKey | HSEMWALZGKQWLK-SWWIKBNJSA-N | ||
Standard InChI | InChI=1S/C74H114N28O20/c1-38(76)59(109)93-47(15-9-25-85-72(77)78)62(112)94-46(14-7-8-24-75)61(111)95-48(16-10-26-86-73(79)80)63(113)97-50(22-23-57(107)108)64(114)96-49(17-11-27-87-74(81)82)65(115)102-58(40(3)104)70(120)100-52(29-42-18-20-45(105)21-19-42)67(117)101-55(35-103)69(119)98-51(28-41-12-5-4-6-13-41)60(110)88-34-56(106)92-53(30-43-32-83-36-89-43)68(118)99-54(31-44-33-84-37-90-44)66(116)91-39(2)71(121)122/h4-6,12-13,18-21,32-33,36-40,46-55,58,103-105H,7-11,14-17,22-31,34-35,75-76H2,1-3H3,(H,83,89)(H,84,90)(H,88,110)(H,91,116)(H,92,106)(H,93,109)(H,94,112)(H,95,111)(H,96,114)(H,97,113)(H,98,119)(H,99,118)(H,100,120)(H,101,117)(H,102,115)(H,107,108)(H,121,122)(H4,77,78,85)(H4,79,80,86)(H4,81,82,87)/t38-,39-,40+,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,58-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Peptide substrate for Akt/PKB. Acts as an inhibitor and mimics the optimal phosphorylation sequence of Akt. |
AKTide-2T Dilution Calculator
AKTide-2T Molarity Calculator
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Dexfenfluramine hydrochloride
Catalog No.:BCC5927
CAS No.:3239-45-0
- Imetit dihydrobromide
Catalog No.:BCC6768
CAS No.:32385-58-3
- Medicarpin
Catalog No.:BCN5241
CAS No.:32383-76-9
- 9,9-Bis(4-hydroxyphenyl)fluorene
Catalog No.:BCC8795
CAS No.:3236-71-3
- 4-Nitrobenzyl carbamate
Catalog No.:BCN3286
CAS No.:32339-07-4
- p-Cresyl sulfate
Catalog No.:BCC4013
CAS No.:3233-58-7
- SCS
Catalog No.:BCC7266
CAS No.:3232-36-8
- Triphosgene
Catalog No.:BCC2848
CAS No.:32315-10-9
- H-Threoninol
Catalog No.:BCC2705
CAS No.:3228-51-1
- 4-Methoxy-1-methylquinolin-2-one
Catalog No.:BCN4824
CAS No.:32262-18-3
- Methyl 3-cyclopropyl-3-oxopropionate
Catalog No.:BCC9038
CAS No.:32249-35-7
- SCH 221510
Catalog No.:BCC7612
CAS No.:322473-89-2
- Vitexin-4'-Rhamnoside(Rg)
Catalog No.:BCC8369
CAS No.:32426-34-9
- Isofebrifugine
Catalog No.:BCN3270
CAS No.:32434-44-9
- H-D-Cys-OH.H2O.HCl
Catalog No.:BCC2913
CAS No.:32443-99-5
- Khasianine
Catalog No.:BCN2530
CAS No.:32449-98-2
- 20(29)-Lupene-3,23-diol
Catalog No.:BCN5242
CAS No.:32451-85-7
- Isochlorogenic acid
Catalog No.:BCN5910
CAS No.:534-61-2
- NPS-2143 hydrochloride
Catalog No.:BCC1808
CAS No.:324523-20-8
- 1-Indanamine hydrochloride
Catalog No.:BCC8467
CAS No.:32457-23-1
- T 0156 hydrochloride
Catalog No.:BCC5803
CAS No.:324572-93-2
- Periplocymarin
Catalog No.:BCN8485
CAS No.:32476-67-8
- Myricanone
Catalog No.:BCN5243
CAS No.:32492-74-3
- Isorhapotogenin
Catalog No.:BCN3383
CAS No.:32507-66-7
Heat shock protein 27 controls apoptosis by regulating Akt activation.[Pubmed:12740362]
J Biol Chem. 2003 Jul 25;278(30):27828-35.
Activation of the serine-threonine kinase Akt by cytokines, chemokines, and bacterial products delays constitutive neutrophil apoptosis, resulting in a prolonged inflammatory response. We showed previously that Akt exists in a signaling complex with p38 MAPK, MAPK-activated protein kinase-2 (MAPKAPK-2), and heat shock protein-27 (Hsp27); and Hsp27 dissociates from the complex upon neutrophil activation. To better understand the regulation of this signaling module, the hypothesis that Akt phosphorylation of Hsp27 regulates its interaction with Akt was tested. The present study shows that Akt phosphorylated Hsp27 on Ser-82 in vitro and in intact cells, and phosphorylation of Hsp27 resulted in its dissociation from Akt. Additionally, the interaction between Hsp27 and Akt was necessary for activation of Akt in intact neutrophils. Constitutive neutrophil apoptosis was accelerated by sequestration of Hsp27 from Akt, and this enhanced rate of apoptosis was reversed by introduction of constitutively active recombinant Akt. Our results define a new mechanism by which Hsp27 regulates apoptosis, through control of Akt activity.
Peptide and protein library screening defines optimal substrate motifs for AKT/PKB.[Pubmed:10945990]
J Biol Chem. 2000 Nov 17;275(46):36108-15.
AKT was originally identified as a proto-oncogene with a pleckstrin homology and Ser/Thr protein kinase domains. Recent studies revealed that AKT regulates a variety of cellular functions including cell survival, cell growth, cell differentiation, cell cycle progression, transcription, translation, and cellular metabolism. To clarify the substrate specificity of AKT, we have used an oriented peptide library approach to determine optimal amino acids at positions N-terminal and C-terminal to the site of phosphorylation. The predicted optimal peptide substrate (Arg-Lys-Arg-Xaa-Arg-Thr-Tyr-Ser*-Phe-Gly where Ser* is the phosphorylation site) has similarities to but is distinct from optimal substrates that we previously defined for related basophilic protein kinases such as protein kinase A, Ser/Arg-rich kinases, and protein kinase C family members. The positions most important for high V(max)/K(m) ratio were Arg-3>Arg-5>Arg-7. The substrate specificity of AKT was further investigated by screening a lambdaGEX phage HeLa cell cDNA expression library. All of the substrates identified by this procedure contained Arg-Xaa-Arg-Xaa-Xaa-(Ser/Thr) motifs and were in close agreement with the motif identified by peptide library screening. The results of this study should help in prediction of likely AKT substrates from primary sequences.